Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Theranostic Radiopharmaceuticals”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Testing effectiveness (Phase 2)Looking for participantsNCT06726161
What this trial is testing

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
RayzeBio, Inc. 590
Very early researchStudy completedNCT07299253
What this trial is testing

Preclinical Safety Evaluation and First-in-Human Translational Study of [177Lu]Lu-TEFAPI-06

Who this might be right for
Metastatic Solid Tumors (Any Localization)
Lanzhou University Second Hospital 5
Very early researchLooking for participantsNCT07608848
What this trial is testing

First-in-human Diagnostic Imaging Profile of the Theranostic Pair [68Ga]Ga-DOTA-STR-17126 and Low Dose [177Lu] Lu-DOTA-STR-17126 in Patients With Advanced or Metastatic Cancer

Who this might be right for
Metastatic Breast CancerMetastatic Prostate CancerGRPR-Targeted Molecular Imaging+5 more
Integrated Haematology and Oncology Network 20
Testing effectiveness (Phase 2)Temporarily pausedNCT06955169
What this trial is testing

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

Who this might be right for
Intracranial Meningioma
RTOG Foundation, Inc. 153
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07434180
What this trial is testing

Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary

Who this might be right for
Cancer of Unknown Primary
Peter MacCallum Cancer Centre, Australia 20
Testing effectiveness (Phase 2)Looking for participantsNCT05655312
What this trial is testing

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

Who this might be right for
Recurrent Melanoma (Skin)Metastatic MelanomaMelanoma Stage IV+1 more
Perspective Therapeutics 300
Early research (Phase 1)Looking for participantsNCT07076550
What this trial is testing

A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma

Who this might be right for
Melanoma MetastaticUveal Melanoma, MetastaticMucosal Melanoma
Alpha-9 Oncology USA Inc. 50
Testing effectiveness (Phase 2)Looking for participantsNCT05636618
What this trial is testing

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

Who this might be right for
Neuroendocrine Tumors UnresectableNeuroendocrine Tumor MetastaticGastroenteropancreatic Neuroendocrine Tumor+4 more
Perspective Therapeutics 300
Early research (Phase 1)Looking for participantsNCT07156565
What this trial is testing

Actinium Therapy for Late-stage Aggressive Sarcomas

Who this might be right for
Advanced Soft Tissue Sarcoma
Ratio Therapeutics, Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT05363605
What this trial is testing

[225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorHead and Neck Squamous Cell CarcinomaBladder Carcinoma+11 more
Fusion Pharmaceuticals Inc. 6
Not applicableNot Yet RecruitingNCT07221825
What this trial is testing

Low-Count Quantitative SPECT for Men Treated With Radium-223

Who this might be right for
Prostate CancerCancer of the Prostate
Washington University School of Medicine 38
Early research (Phase 1)Study completedNCT04904120
What this trial is testing

Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy

Who this might be right for
Melanoma (Skin)Melanoma Stage IVMelanoma, Uveal+1 more
Perspective Therapeutics 7